Laxium

Quick links to important sections

Laxium

Method of action: Laxative

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Laxium

Quick Facts: Laxium (Bisacodyl)

Property Description
Active ingredient Bisacodyl
Forms Enteric-coated tablets, Suppositories
Pharmacological class Stimulant laxative
Common use Relief of constipation / Bowel evacuation
Origin Synthetic compound

What is Laxium? Definition and Pharmacological Classification

Laxium is a medication defined by its single active component, Bisacodyl, which functions to promote bowel evacuation. It is fundamentally classified as a Stimulant laxative, a category often identified as a Contact laxative or Purgative, noted for its active effect on intestinal motility. The active compound, Bisacodyl, is a synthetic compound derived from the Diphenylmethane chemical group, meaning its structure is designed to execute a specific, localized function within the digestive tract.

Bisacodyl is characterized as an agent that works directly to increase the movement of stool through the colon. The medication's mechanism is designed for predictable action on intestinal muscle contraction.


Composition, Forms, and General Therapeutic Purpose

The identity of Laxium is characterized by its core active substance, Bisacodyl, and its primary preparations: enteric-coated tablets and suppositories. The enteric-coated tablets are formulated for the oral route and are designed to resist dissolution in the stomach, a design feature to ensure the Bisacodyl reaches the large intestine intact to perform its function locally. The alternative form, suppositories, is prepared for the rectal route and is intended to provide effect closer to the distal colon. This differentiation in forms allows the medicine to be used in various settings, such as preparing the bowel for a medical procedure.

The general therapeutic purpose of Laxium is to relieve the symptoms associated with short-term, episodic constipation by promoting efficient bowel evacuation. Bisacodyl acts to facilitate the elimination of accumulated material by promoting movement within the intestine. By targeting the processes of intestinal muscle contraction and fluid balance, this medication is used to restore a more efficient digestive transit time.

What side effects are possible with Laxium?

Possible side effects and safety information

The official safety profile for Laxium (Bisacodyl), established by government regulatory authorities, primarily documents adverse reactions related to its action within the gastrointestinal system.

Frequency-Classified Adverse Reactions

Adverse effects are categorized based on their documented frequency in clinical data, following regulatory standards:

  • Common Reactions: Abdominal pain, abdominal discomfort, diarrhea, and nausea are the most frequently reported effects.
  • Uncommon Reactions: These include vomiting, anorectal discomfort, dizziness, and haematochezia (blood in stool).
  • Rare Reactions: Clinically significant reactions documented as rare include syncope (fainting), severe dehydration, colitis (including ischaemic colitis), and hypersensitivity reactions such as angioedema.

Regulatory Safety Considerations

The medicine's safety profile includes specific limitations and warnings documented in official labeling:

  • Time- and Duration-Related Patterns: Prolonged or excessive use is strongly associated with the risk of developing fluid and electrolyte imbalance, particularly hypokalemia (low potassium), and dehydration. Regulatory documents caution against continuous daily administration for extended periods.
  • Serious Adverse Reactions: Reactions such as colitis, syncope, and severe dehydration are officially listed due to their potential clinical significance.
  • Population Notes: Safety information indicates that older adults are at a heightened risk for dehydration and subsequent electrolyte disturbances if the medicine is misused. Use in pediatric patients is restricted, often requiring medical supervision as per regulatory guidelines.
  • Contraindications: Laxium is officially restricted in individuals presenting with acute surgical abdominal conditions, intestinal obstruction, and existing severe dehydration.

Overdose and Emergency Response

Overdosing on Laxium (a hypothetical benzodiazepine) can result in an extension of its therapeutic effects, leading to significant central nervous system (CNS) depression. While a pure benzodiazepine overdose is rarely fatal in healthy individuals, it becomes life-threatening when combined with other CNS depressants such as alcohol or opioids.

Signs of Laxium Overdose

Symptoms can range from mild to severe, including:

Mild Symptoms Severe Symptoms (Medical Emergency)
Extreme drowsiness Slow, shallow, or stopped breathing
Confusion or slurred speech Unresponsiveness (inability to be awakened)
Impaired coordination (ataxia) Bluish or pale skin, lips, or fingernails

When to Seek Immediate Help

An overdose is a medical emergency. If you suspect that you or someone else has taken too much Laxium, especially if combined with other depressants, or is exhibiting any of the severe symptoms listed above, you must seek professional medical attention immediately.

  • Call your local emergency number (e.g., 911 in the U.S.).
  • If available, contact a certified Poison Control Center for guidance.

Provide the healthcare providers with as much information as possible, including the dose taken, the time of ingestion, and any other substances or medications consumed.

Therapeutic Uses of Laxium

What Laxium Treats: Main Uses and Benefits

Laxium is commonly used to help with short-term symptomatic support across distinct areas of bowel function, offering focused relief when the digestive system may need assistance with elimination. The medication is used on a short-term basis to treat constipation and is also applied to empty the bowels before surgery and certain medical procedures.

This medication is relevant for easing challenging symptoms related to infrequent bowel movements and hard stool consistency, and may assist with maintaining a sense of stability in digestive transit time. It is applied across conditions presenting with acute episodes of episodic constipation, and in specific clinical settings for necessary bowel preparation before investigational procedures or surgery, as well as to address opioid-induced constipation (OIC). The medication helps address symptom clusters that may become intense or disruptive.


Quick Fact: Supportive Management for Constipation Symptoms

Feature Description
Primary Symptom Infrequent, hard, or difficult-to-pass stools
Typical Contexts Episodic irregularity, Pre-procedural cleansing, Opioid therapy support
Patient Benefit Contributes to easing the overall symptom load during episodes of discomfort
Relief Target Symptoms related to physical discomfort and functional strain

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

The eligibility for using Laxium (Bisacodyl) is strictly defined by regulatory documents, primarily based on age, acute health status, and physiological conditions.

Eligibility Scope

Category Eligibility Status
Allowed Populations Adults and adolescents (generally ge 12 years); children ge 4 or ge 6 years for oral forms under specific age restrictions.
Contraindicated Populations Patients with intestinal obstruction, ileus, acute abdominal conditions (e.g., appendicitis, acute inflammatory bowel diseases), or severe dehydration [1.1, 3.2].
Age-Related Rules The oral tablet is contraindicated in children under 4 years in some regions [2.1]. Use in older adults is permitted but with caution regarding fluid imbalance [1.5, 3.2].
Pregnancy/Lactation Pregnancy: Use is conditional (only if clearly needed and on medical advice) [2.1, 3.2]. Lactation: Generally acceptable as the active metabolite is not detected in breast milk [2.2].
Use Restrictions Restricted to short-term symptomatic use only (typically le 7 days) [1.9, 3.2]. Use is contraindicated for the suppository form in the presence of anal fissures or ulcerative proctitis [3.5].

Eligibility Classifications

Official regulatory documents categorize non-eligibility primarily as Contraindicated (absolute prohibition) or Restricted Use (conditional on age or duration). Individuals with known hypersensitivity to Bisacodyl are absolutely excluded [1.2, 3.2]. The entire eligibility profile is defined by official government prescribing information, which sets mandatory limitations on the user population.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Administration Timing and Formulation-Based Interactions

The official interaction profile for Laxium (Bisacodyl) is defined by regulatory requirements concerning the integrity of the enteric-coated tablet formulation. Bisacodyl must not be taken within one hour of consuming products such as Antacids, Milk/Dairy Products, or Proton Pump Inhibitors (PPIs). This mandatory separation requirement is formally documented to prevent the premature dissolution of the enteric coating, which reduces the effective therapeutic exposure in the large intestine.

Systemic Pharmacodynamic Interactions

Co-administration with certain medicinal products carries a documented risk of electrolyte imbalance. The use of Bisacodyl alongside Diuretics or Adreno-corticosteroids (Steroids) may increase the risk of hypokalemia (low potassium) if significant fluid loss occurs. This change in electrolyte status can increase the sensitivity to Cardiac Glycosides, such as Digoxin, thereby potentiating their toxic effects. Furthermore, the combination of Bisacodyl with other laxatives may enhance the occurrence of gastrointestinal side effects.

Specific caution regarding the use of potassium-lowering agents is noted for elderly patients and those with Renal Insufficiency due to documented heightened susceptibility to electrolyte abnormalities.

Mechanism of Action

How Laxium Works

Laxium's mechanism of action, driven by its active metabolite (BHPM), is a dual-action process localized exclusively to the large intestine. The drug, a prodrug, must first undergo enzymatic hydrolysis by colonic esterases to yield the active BHPM metabolite.

Epithelial Fluid Control: The BHPM metabolite directly targets colonic enterocytes, acting as an inhibitor of the Na^+/ K^+-ATPase pump. This biochemical action disrupts the natural process of water and electrolyte absorption, concurrently promoting fluid secretion into the lumen. The physiological consequence is a net increase in the water and electrolyte content within the colonic lumen.

Modulation of Enteric Motility: Simultaneously, BHPM chemically stimulates the Enteric Nervous System (ENS) nerve plexuses embedded in the colonic wall. This chemical activation enhances the signaling pathways that regulate propulsive peristalsis, leading to an increase in the speed and force of muscle contractions. This enhanced motor activity results in an acceleration of colonic transit and promotes the passage of intestinal contents.

Dosage and Administration Information

How to Use Laxium: Official Administration Guidelines

Laxium (Bisacodyl) is characterized by protocols that define its route, dosage, frequency, and preparation requirements. The medication is available in two primary forms: the 5 mg enteric-coated tablet for the oral route and the 10 mg suppository for the rectal route.

Administration Scope

Usage Parameter Guideline Detail
Routes Oral (tablets) or Rectal (suppositories)
Adult Dosing (ge 12 yrs) Oral dosing typically ranges from 5 mg to 15 mg (one to three tablets) as a single daily dose. The rectal dose is 10 mg (one suppository) in a single daily dose.
Pediatric Dosing (6 to <12 yrs) Administration is limited to 5 mg orally or rectally (one tablet or one half-suppository), taken once daily.
Duration Use is restricted to short-term administration, generally not to exceed seven consecutive days.

Procedural Contextual Instructions

The specific administration method is critical to ensuring the medicine functions as intended. The enteric-coated tablets must be swallowed whole with a sufficient quantity of water and must not be crushed or chewed. This requirement is crucial to prevent the premature release of the active compound in the stomach. The oral dose is typically taken at bedtime to produce an effect approximately 6 to 12 hours later. Furthermore, the labeling indicates that the oral tablet must not be taken within one hour of consuming antacids, milk, or any other product that might alter the acidity of the upper gastrointestinal tract. Rectal suppositories are designed to take effect rapidly, typically within 15 to 60 minutes.

These administration rules establish a clear, standardized protocol for use, defining the exact quantities, timing, and conditions under which the medication is intended to be utilized.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Laxium

Evidence for Use in Chronic and Episodic Constipation

The research base for Laxium (Bisacodyl) primarily consists of randomized controlled trials (RCTs) and meta-analyses that have evaluated its use in conditions characterized by fluctuating or episodic manifestations of constipation. Research examined functional measures like the number of complete spontaneous bowel movements (CSBMs) per week. The studies also monitored patient-reported outcomes describing perceived discomfort and used specific quality-of-life scores to examine daily functioning or activity level.

Findings describe patterns observed in the studies where, over short intervention periods (typically up to four weeks), measurements of weekly CSBMs were observed in the active treatment groups, with some reports noting higher frequency compared to placebo groups. Studies also described symptom patterns in the observed populations, and some reports documented measurements of stool consistency being different among participants receiving the medication.

The evidence base is considered substantial for short-term use in adults with chronic constipation. However, there is limited information for long-term outcomes; the effects and tolerability of use over many months are not fully established by controlled research.

Evidence for Bowel Preparation Before Medical Procedures

Laxium was studied for its use in preparing the bowel for procedures such as colonoscopy. The research describes patterns where regimens including Bisacodyl were associated in some studies with satisfactory cleansing scores for the procedure. Researchers also monitored outcomes related to physical discomfort, assessing the patient experience and tolerability of the preparation regimen.

Research Context for Opioid-Induced Constipation

Research reports and guidelines described the study of stimulant laxatives (like Bisacodyl) in the context of OIC management protocols. Evidence has explored whether this pharmacological class is relevant to managing conditions marked by functional limitations. Often, the research was conducted in studies where Bisacodyl served as a standard comparator.

Key Limitations and Uncertainties in Research

  • Follow-up durations were limited in most randomized trials, which provides research context for acute, short-term use but less certainty regarding sustained management.
  • Data for certain groups are limited, particularly for long-term use and some comorbidity-defined populations.
  • Evidence quality varies across studies, with some findings being mixed, especially when comparing Bisacodyl across many different treatment categories.

Key Studies & References

  1. Bisacodyl: MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Laxium (FAQ)

Q: Is it normal to feel tired when first starting Laxium?

Official product information lists side effects such as dizziness and syncope (fainting), which may affect alertness. However, general fatigue or tiredness is not typically listed among the common reactions documented in the main regulatory sources.

Q: Can I take Laxium if I already take a vitamin supplement?

While regulatory documents do not generally list direct drug-drug interactions between Laxium and common vitamin supplements, official sources indicate the importance of discussing all supplements with a healthcare professional.

Q: How long does Laxium stay in your system?

The medicine is primarily designed to act locally in the colon. For the oral tablet form, the active substance has an estimated plasma elimination half-life of approximately 7.7 hours. This refers to the time it takes for half of the substance that enters the bloodstream to be eliminated.

Q: What happens if I forget to take a dose of Laxium?

Laxium is typically taken only as needed. If the medication has been prescribed for regular use, regulatory patient information describes common protocols for missed doses, such as taking the dose if remembered soon after the scheduled time, or skipping it and continuing the regular routine if the next dose is near.

Q: Is Laxium known to interact with common pain relievers like ibuprofen?

Laxium is not commonly listed in official documents as having a direct interaction with NSAIDs, a class of pain relievers that includes ibuprofen. However, in specific situations like bowel preparation, some regulatory guidance has described scenarios where NSAIDs might be avoided to reduce the risk of kidney-related complications due to potential dehydration.

Q: What should I do if a side effect of Laxium doesn't go away?

Official patient information notes that if certain side effects become severe or persist, or if specific critical events such as rectal bleeding occur, the regulatory document instructs that the use of the product should be discontinued. These events are also designated as requiring immediate communication with a healthcare professional.

Q: Does taking Laxium affect the results of blood tests?

Official patient information in some regions advises that Laxium may interfere with the results of certain blood tests. In particular, long-term or excessive use can lead to fluid loss and electrolyte imbalance, which affects levels like potassium that are monitored in blood tests.

Q: Does Laxium cause weight changes?

Official patient information explicitly states that this medicine is not intended to help with weight loss. While temporary fluid-related weight fluctuations can occur due to the rare side effect of dehydration, Laxium is not classified as a drug for promoting weight change.

Q: Can I drink alcohol while taking Laxium?

Regulatory guidance indicates that no direct interaction is known between Laxium and alcohol. Based on official sources, no direct interaction between Laxium and alcohol is generally noted in regulatory documents.

Q: What is the proper way to stop taking Laxium?

Regulatory documents define this product as being for short-term use only, with continuous daily use generally restricted to seven days or less. The short-term nature of the product implies that use is ceased once the temporary treatment period is completed.

Q: Does Laxium have any known interactions with herbal supplements?

Official regulatory sources state there is insufficient evidence to confirm that all complementary or herbal medicines are safe to take with Laxium. Due to this uncertainty, regulatory communications stress the importance of discussing the use of any herbal supplements with a healthcare professional.

Q: Is Laxium described as a Schedule [X] drug in official sources?

Laxium (Bisacodyl) is not classified as a controlled substance or scheduled drug by major regulatory authorities like the U.S. DEA.

Q: What is the purpose of the initial testing or check-ups before starting Laxium?

Regulatory warnings emphasize the risk of dehydration and electrolyte imbalance. Regulatory information indicates that healthcare professionals check for the absence of absolute contraindications before use, such as severe dehydration or acute abdominal conditions, due to the risks emphasized in regulatory warnings.

Q: Does Laxium interact with birth control pills?

Laxium is generally not listed as interacting with hormonal birth control pills. However, if the use of Laxium causes severe diarrhea that persists for more than 24 hours, regulatory information notes that patients may need to check the guidance for their specific contraceptive product concerning potential changes in effectiveness.

Q: Why do some users report headaches when taking Laxium?

Headache is listed as an adverse reaction in clinical trial reports for Bisacodyl, with some studies showing it as a commonly reported effect, especially when used in higher doses for bowel preparation regimens.

Q: Do I need to change my diet while taking Laxium?

While official labeling does not require specific changes, official regulatory guidance often emphasizes the role of a high-fiber diet, adequate liquid intake, and a regular exercise program in supporting regular bowel function.

Q: Are there any food or drinks that should be avoided with Laxium?

Official documents stipulate that oral tablets should not be taken within one hour of consuming milk, dairy products, or antacids. This restriction is formally documented to prevent the premature dissolution of the enteric coating, which could lead to reduced effectiveness and gastric irritation.

Q: Why do some people say Laxium did not work for them?

Regulatory information emphasizes specific administration procedures, such as swallowing the enteric-coated tablets whole and avoiding milk near dosing. Deviations from these procedures, or the presence of specific underlying factors, may contribute to a perceived lack of effect.

Q: Can people with kidney problems use Laxium?

Use in patients with renal insufficiency (kidney problems) is permitted but involves restrictions. If significant fluid loss occurs and dehydration becomes a concern, regulatory documents note that the medicine's use is subject to review, and the medication is typically discontinued and its reintroduction managed by a healthcare professional.

Q: Is there a risk of becoming dependent on Laxium?

Regulatory documents caution that frequent or continued use beyond the short-term recommendation has been associated with the risk of the bowels becoming reliant on laxatives to function. This prolonged use is also associated with the risk of fluid and electrolyte imbalance.

Q: Is Laxium safe for people with a history of heart issues?

Laxium is locally acting, but its prolonged, excessive use can lead to hypokalemia (low potassium). Official information indicates that this electrolyte imbalance has the potential to increase sensitivity to certain cardiac medications, such as cardiac glycosides (Digoxin).

Q: Are the research findings on Laxium based on large-scale studies?

The evidence base is considered substantial for short-term use, relying primarily on randomized controlled trials (RCTs) and meta-analyses. These study types are often large-scale and generally contributes to a substantial evidence base for the medicine's documented uses.

Q: Can Laxium affect my ability to drive or operate machinery?

Official prescribing information advises that side effects like dizziness, syncope (fainting), or abdominal spasm may occur. Regulatory documents note that if a patient experiences these effects, particularly abdominal spasm, they are instructed to avoid driving or operating machinery.

Q: What happens if I take Laxium on an empty stomach?

The oral tablet is typically taken at bedtime, which is often close to an empty stomach. The main restriction is described as the tablet not being taken within one hour of consuming milk, antacids, or proton pump inhibitors (PPIs) to ensure the coating remains intact.

Q: Can Laxium be taken with blood pressure medication?

Regulatory documents note a specific interaction: co-administration with diuretics (a common type of blood pressure medicine) may increase the risk of an electrolyte imbalance, specifically low potassium, if excessive doses are taken.

Q: Is it necessary to take Laxium at the exact same time every day?

The oral dose is usually taken at bedtime to ensure a consistent effect the next morning. Since the product is intended for short-term, episodic relief, the regulatory guidance emphasizes the bedtime routine for convenience, rather than mandating an exact clock time every day.

How should Laxium be stored and disposed of?

How to Store and Dispose of Laxium?

Laxium must be stored at Controlled Room Temperature, specifically between 20 C and 25 C (68 F and 77 F), with excursions permitted up to 30 C. The product must be protected from excessive moisture and excessive heat to maintain stability.

Storage Requirements

  • Container: Keep the medication in the original container and ensure the container is tightly closed.
  • Protection: It must be stored out of the sight and reach of children.

Disposal Instructions

Any unused or expired Laxium must be disposed of according to local regulations. Regulatory documents advise against disposing of the product via wastewater or ordinary household waste to prevent environmental discharge.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Laxium found in:

A-Z Index: